donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

06833 Sinco Pharmaceuticals

1.220
-0.010-0.81%
Market Close 06/28 16:08 CCT
High
1.300
Open
1.300
Turnover
10.93M
Low
1.210
Pre Close
1.230
Volume
8.87M
Market Cap
2.48B
P/E(TTM)
15.06
52wk High
2.320
Shares
2.03B
P/E(Static)
15.06
52wk Low
0.530
Float Cap
2.48B
Bid/Ask %
-55.40%
Historical High
2.320
Shs Float
2.03B
Volume Ratio
1.03
Historical Low
0.146
Dividend TTM
--
Div Yield TTM
--
P/B
5.40
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.44%
Amplitude
7.32%
Avg Price
1.232
Lot Size
4000
Float Cap
2.48B
Bid/Ask %
-55.40%
Historical High
2.320
Shs Float
2.03B
Volume Ratio
1.03
Historical Low
0.146
Dividend TTM
--
P/B
5.40
Dividend LFY
--
Turnover Ratio
0.44%
Amplitude
7.32%
Avg Price
1.232
Lot Size
4000
Price Forecast

No Data

News

Comment

Sign in to post a comment

    No comment yet

    Company Overview More
    Xingke Rong Pharmaceutical Holdings Co., Ltd. mainly provides marketing, promotion and channel management (MPCM) services in the pharmaceutical industry of the people's Republic of China. The company provides comprehensive MPCM services to small and medium-sized overseas pharmaceutical manufacturers that do not have independent marketing and promotion capabilities in China. Its main product is human serum albumin injection. The product is a human serum albumin produced by Octapharma for the treatment of hypovolemic and hypovolemic shock, abnormally high intracranial pressure, edema and ascites, as well as the prevention and treatment of hypoalbuminemia and neonatal hyperbilirubinemia. In addition, its products include Ankexin, McDonnell, Elsaif, Tate and Torot and so on.
    CEO: Xiangbin Huang
    Market: Hong Kong motherboard
    Hot List
    TradeSearchNews
    SymbolLatest price%Chg

    Loading...